Yingnan Yu

发表

Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.

P. Tan, B. Bay, M. Tsujimoto, 2010, International journal of oncology.

Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review

C. Khor, B. Chowbay, N. Sutiman, 2016, Drug metabolism reviews.

Silencing the YB‐1 Gene Inhibits Cell Migration in Gastric Cancer In Vitro

B. Bay, Ken Matsumoto, Yingnan Yu, 2013, Anatomical record.

Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer

P. Tan, Ken Matsumoto, Agus Salim, 2015, Experimental biology and medicine.

Surmounting Chemoresistance by Targeting the Y‐Box Binding Protein‐1

B. Bay, Ken Matsumoto, Yingnan Yu, 2012, Anatomical record.

Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.

P. Tan, B. Bay, G. Yip, 2010, International journal of oncology.

Y‐box binding protein 1 is correlated with lymph node metastasis in intestinal‐type gastric cancer

P. Tan, B. Bay, T. Lim, 2015, Histopathology.

TP53 Genomic Status Regulates Sensitivity of Gastric Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A (DZNep)

Qiang Yu, Na-Yu Chia, B. Bay, 2012, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine TP 53 GenomicStatusRegulates Sensitivity of GastricCancer Cells to the HistoneMethylation Inhibitor 3-Deazaneplanocin A ( DZNep )

P. Tan, Qiang Yu, Na-Yu Chia, 2012 .

Breast cancer metastasis.

B. Bay, G. Yip, Yingnan Yu, 2012, Cancer genomics & proteomics.

Association of LINC-PINT polymorphisms with lumbar disc herniation risk among Chinese Han population: a case control study

Yingnan Yu, Yu-Peng Wang, Yimin Wu, 2023, Journal of Orthopaedic Surgery and Research.

Breast cancer metastasis.

G. Yip, Yingnan Yu, O. J. Scully, 2012, Cancer genomics & proteomics.